ARTELO BIOSCIENCES, INC. (ARTL) IPO - S-1 Filing, Stock & Insider Activity
ARTELO BIOSCIENCES, INC. IPO - Status & S-1 Filing
- Ticker: ARTL
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-11-17
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 1,641,587
- SEC CIK: 0001621221 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
ARTELO BIOSCIENCES, INC. (ARTL) has filed 6 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-21. 3 Form 8-K material event filings were reported by ARTL in the last 90 days. InsiderAlpha tracks every ARTL SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About ARTELO BIOSCIENCES, INC. (ARTL)
ARTELO BIOSCIENCES, INC. trades under the ticker ARTL. InsiderAlpha tracks 24 primary SEC Form 4 filings from 8 reporting insiders for ARTL since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001621221 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 6 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-07-21 |
Most-Active ARTL Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Connie Matsui | 1 | - |
| Tamara A. Favorito | 1 | - |
| Robert Martin Emanuele | 1 | - |
| Steven Kelly | 1 | - |
| Gregory Reyes | 1 | - |
Recent ARTL Form 8-K Material Events
- - Item 5.07 [SEC]
- - Item 1.01, 8.01, 9.01 [SEC]
- - Item 1.02 [SEC]
- - Item 8.01, 9.01 · Regulatory · positive [SEC]
Artelo Biosciences received confirmation from Nasdaq on April 6, 2026, that it has regained compliance with two listing rules: the stockholders' equity requirement (minimum $2.5 million) and the annual meeting requirement. However, the company remains subject to a mandatory panel - - Item 1.01, 3.02, 7.01, 8.01, 9.01 · Financing · mixed [SEC]
Artelo Biosciences completed a private placement on March 30, 2026, issuing 81,000 common shares at $3.45/share, 3.1M pre-funded warrants at $0.001/share, and 6.4M common warrants at $3.20/share to accredited investors. The offering raises approximately $280K in gross proceeds fr
Recent Insider Filings
- - Connie Matsui (Insider)
- - Douglas Blayney (Insider)
- - Gregory Reyes (Insider)
- - Robert Martin Emanuele (Insider)
- - Steven Kelly (Insider)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ARTL insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
ARTL Insider Trading - FAQ
- What is the latest insider trade for ARTL?
- ARTELO BIOSCIENCES, INC. (ARTL) had 6 insider filings in the last 90 days, with the most recent on 2026-07-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying ARTL stock?
- 0 insider purchases of ARTL were filed in the last 90 days.
- How many insiders are selling ARTL stock?
- 0 insider sales of ARTL were filed in the last 90 days.
- Where can I see ARTL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks ARTL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $ARTV Artiva Biotherapeutics, Inc.
- $ASMB ASSEMBLY BIOSCIENCES, INC.
- $ATAI ATAI Life Sciences N.V.
- $AUPH Aurinia Pharmaceuticals Inc.
- $AWHL Aspira Women's Health Inc.
- $BCAX Bicara Therapeutics Inc.
- $BCYC BICYCLE THERAPEUTICS PLC
- $BFLY Butterfly Network, Inc.
- $BFRG BullFrog AI Holdings, Inc.
- $BFRI Biofrontera Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live ARTL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.